Schedule 13D ownership disclosure

RANI THERAPEUTICS HLDGS INC

Security class unavailable · CUSIP: 753018100

Event date: 2023-03-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
27.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-032653
Form type
SC 13D/A
Filer
Rani Therapeutics Holdings, Inc.
CIK
CIK 1856725
Filed
Mar 15, 2023
Reporting period
Mar 13, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub